Assessing risk factors for nonhemorrhagic stroke after acute myocardial infarction

We studied 247 (0.6%) of the 41,021 patients enrolled in the GUSTO-I trial who had suffered a nonhemorrhagic stroke. Of this subset, 42 (17%) died and 98 (40%) were disabled within 30 days. Advanced age was the most important baseline clinical predictor of nonhemorrhagic stroke, followed by increased heart rate, history of stroke or transient ischemic attack, diabetes, previous angina, and history of hypertension. Using these baseline clinical characteristics, we developed a simple nomogram that can predict the risk of non-hemorrhagic stroke.

Duke Scholars

Author Christopher Bull Granger Medicine, Cardiology